Neurona Therapeutics
Neurona Therapeutics is a biotechnology company developing engineered cell-based therapies designed to restore or modulate neuronal circuits for the treatment of neurological disorders. The company applies human neuronal cell engineering and targeted delivery approaches to create therapeutic candidates intended to provide durable functional benefit in diseases driven by circuit dysfunction.
Leadership & Board
- Current Number of Employees
- 119
- Current LinkedIn Followers
- 12,363
Latest Estimated Valuation
- Estimated Valuation
- ―
- Total Amount Raised
- $14M
- Total Funding Rounds
- 1
- Latest Funding Amount
- $14M
- Latest Funding Round
- Investment
- Post-Money Valuation
- ―
Employee Trend
Neurona Therapeutics had 119 employees as of October 12, 2026. The number of employees decreased by 1 (0.83%) week-over-week.
Social Trend
Neurona Therapeutics had 12,363 followers as of October 12, 2026. The number of followers increased by 68 (0.55%) week-over-week.
Funding Round
| Funding Date | Funding Round | Amount Raised | Post-Money Valuation |
|---|---|---|---|
| Jul 18, 2025 | Investment | $14.00M | ― |
Investors
| Investor Name | Funding Round |
|---|---|
| California Institute for Regenerative Medicine | Investment |
Similar Companies
A snapshot of private companies similar to Neurona Therapeutics, helping you discover and navigate related company profiles.
Related News and Analysis
